medigraphic.com
ISSN 2078-7170 (Electronic)

2019, Number 4

<< Back Next >>

CorSalud 2019; 11 (4)

Current regenerative therapy: Induced embryonic and pluripotential stem cells, angiogenic growth factor and gene therapy

Hidalgo DJR, Chachques JC, Paredes CÁ

Language: Spanish
References: 14
Page: 302-306
PDF size: 354.60 Kb.


Text Extraction

There is no doubt that the most recent discovery of Regenerative Medicine is iPS (Induced Pluripotent Stem cells), also called Reprogrammable Adult Stem Cells (SC), "third way cells" or Induced Pluripotency Stem Cells. John Gurdon from the UK and Shinya Yamanaka from Kyoto University in Japan were awarded the Nobel Prize for Medicine precisely for their research on Stem Cells.


REFERENCES

  1. Hidalgo Díaz J. Las células madre y sus debates: nociones muy básicas. ContraPunto [Internet]. 2019 [citado 18 Dic 2018]. Disponible en: https://www.contrapunto.com.sv/opinion/academia/las-celulas-madre-y-sus-debates-nociones-muy-basicas/9257

  2. Johnson MH, Cohen J. Reprogramming rewarded: the 2012 Nobel Prize for Physiology or Medicine awarded to John Gurdon and Shinya Yamanaka. Reprod Biomed Online. 2012;25(6):549-50.

  3. Yamanaka S. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell. 2012;10(6):678-84.

  4. Hidalgo Díaz J. Las células madre y sus debates: nociones muy básicas para no entendidos. Te-mas [Internet] 2017 [citado 18 Dic 2018]. Disponi-ble en: http://www.temas.cult.cu/catalejo/las-c-lulas-madre-y-sus-debates-nociones-muy-b-sicas-para-no-entendidos

  5. Feldman DE, Chen C, Punj V, Tsukamoto H, Ma-chida K. Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to on-cogenesis through tumor-initiating stem cells. Proc Natl Acad Sci USA. 2012;109(3):829-34.

  6. Hernández Cañero A, Hidalgo Díaz J. La regene-ración del corazón y la terapia celular con células madre. Rev CENIC Ciencias Biol. 2004;35(3):210-11.

  7. Hidalgo Díaz JR, Hernández Cañero A, Chach-ques JC, Paredes Cordero A. Células madre me-senquimales de médula ósea y de cordón umbili-cal en el tratamiento de enfermedades cardiovas-culares. CorSalud [Internet]. 2018 [citado 20 Dic 2018];10(1):47-51. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/294/628

  8. Chachques JC, Duarte F, Cattadori B, Shafy A, Lila N, Chatellier G, et al. Angiogenic growth factors and/or cellular therapy for myocardial regenera-tion: a comparative study. J Thorac Cardiovasc Surg. 2004;128(2):245-53.

  9. Gálvez-Montón C, Prat-Vidal C, Roura S, Soler-Botija C, Bayes-Genis A. Ingeniería tisular cardia-ca y corazón bioartificial. Rev Esp Cardiol. 2013; 66(5):391-9.

  10. Nadal-Ginard B. Inducción de nuevos cardiomio-citos en el corazón adulto: futuro de la regenera-ción miocárdica como alternativa al trasplante. Rev Esp Cardiol. 2001;54(5):543-50.

  11. Jhala D, Rather H, Kedaria D, Shah J, Singh S, Va-sita R. Biomimetic polycaprolactone-chitosan nanofibrous substrate influenced cell cycle and ECM secretion affect cellular uptake of nanoclus-ters. Bioact Mater. 2018;4(1):79-86.

  12. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circula-tion. 2003;107(18):2294-302.

  13. Chachques JC, Hidalgo J, Cattadori B, Duarte F, Shafy A, Argyriadis P, et al. Cardiomioplastia Ce-lular: Un nuevo enfoque terapéutico para la dis-función ventricular. Cardiología Intercontinental. 2001;10(1):11-5.

  14. Mathison M, Gersch RP, Nasser A, Lilo S, Korman M, Fourman M, et al. In vivo cardiac cellular re-programming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J Am Heart Assoc [Internet]. 2012 [citado 20 Dic 2018];1(6): e005652. Disponible en: https://www.ahajournals.org/doi/pdf/10.1161/JAHA.112.005652




2020     |     www.medigraphic.com